Brief: Cansino Biologics Swings To Net Loss Of 909.4 Mln Yuan In 2022
27/03/2023 12:12
March 27 (Reuters) - CanSino Biologics Inc 688185.SS :
* SAYS 2022 NET LOSS OF 909.4 MILLION YUAN ($132.14
million) VS
NET PROFIT OF 1.9 BILLION YUAN YEAR EARLIER
Source text
Further company coverage: 688185.SS
($1 = 6.8820 Chinese yuan renminbi)
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Cansino Biologics
See all newsBrief: CanSino Biologics Says China's NMPA Granted Priority Review Status To NDA For TD5CP Adolescent, Adult
Brief: CanSino Biologics Reports Widened Net Loss For Q1
Brief: CanSino Biologics Says 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Prelim 2025 Net Profit At 27.9 Million Yuan
Brief: CanSino Biologics Expects To Have Returned to Net Profit In 2025